Estados Unidos - inglés - NLM (National Library of Medicine)

the body shop wake forest - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - octinoxate 3.75 mg in 0.5 ml - - helps prevent sunburn. - higher spf gives more protection.

Estados Unidos - inglés - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - temazepam (unii: chb1qd2qss) (temazepam - unii:chb1qd2qss) - temazepam 30 mg - temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days). for patients with short-term insomnia, instructions in the prescription should indicate that temazepam capsules should be used for short periods of time (7 to 10 days). the clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment. benzodiazepines may cause fetal harm when administered to a pregnant woman. an increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. transplacental distribution has resulted in neonatal cns depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. reproduction studies in animals with temazepam were performed in rats and rabbits. in a perinatal-postnatal study in rats, oral doses of 60 mg/kg/day result

Estados Unidos - inglés - NLM (National Library of Medicine)

topco associates, llc - caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - caffeine 200 mg - alertness aid helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

Estados Unidos - inglés - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - temazepam (unii: chb1qd2qss) (temazepam - unii:chb1qd2qss) - temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days). for patients with short-term insomnia, instructions in the prescription should indicate that temazepam capsules should be used for short periods of time (7 to 10 days). the clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment. benzodiazepines may cause fetal harm when administered to a pregnant woman. an increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. transplacental distribution has resulted in neonatal cns depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. reproduction studies in animals with temazepam were performed in rats and rabbits. in a perinatal-postnatal study in rats, oral doses of 60 mg/kg/day result

Estados Unidos - inglés - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - temazepam (unii: chb1qd2qss) (temazepam - unii:chb1qd2qss) - temazepam capsules, usp are indicated for the short-term treatment of insomnia (generally 7 to 10 days). for patients with short-term insomnia, instructions in the prescription should indicate that temazepam capsules should be used for short periods of time (7 to 10 days). the clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment. benzodiazepines may cause fetal harm when administered to a pregnant woman. an increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. transplacental distribution has resulted in neonatal cns depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. reproductio

Estados Unidos - inglés - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - zolpidem tartrate (unii: wy6w63843k) (zolpidem - unii:7k383oqi23) - zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see clinical studies (14)]. the clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. zolpidem tartrate is contraindicated in patients with known hypersensitivity to zolpidem. observed reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. risk summary neonates born to mothers using zolpidem late in the third trimester of pregnancy have been reported to experience symptoms of respiratory depression and sedation [see clinical considerations and data] . published data on the use of zolpidem during pregnancy have not reported a clear association with zolpidem and major birth defects [s

Turquía - turco - TİTCK (Türkİye İlaç Ve Tibbİ Cİhaz Kurumu)

genveon İlaÇ san. ve tİc. a.Ş. - modafinil - modafinil

Turquía - turco - TİTCK (Türkİye İlaç Ve Tibbİ Cİhaz Kurumu)

genveon İlaÇ san. ve tİc. a.Ş. - modafinil - modafinil

Turquía - turco - TİTCK (Türkİye İlaç Ve Tibbİ Cİhaz Kurumu)

abdİ İbrahİm İlaÇ san. ve tİc. a.Ş. - sugammadeks sodyum -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

vibe culture - leucine, quantity: 23.81 mg/g; isoleucine, quantity: 11.9 mg/g; valine, quantity: 11.9 mg/g; glutamine, quantity: 47.62 mg/g; sodium chloride, quantity: 17.14 mg/g (equivalent: sodium, qty 6.74 mg/g); cysteine, quantity: 11.9 mg/g; rhodiola rosea, quantity: 11.9 mg/g (equivalent: rhodiola rosea, qty 95.2 mg/g); potassium chloride, quantity: 9.52 mg/g (equivalent: potassium, qty 4.99 mg/g); silybum marianum, quantity: 7.14 mg/g (equivalent: silybum marianum, qty 142.8 mg/g); opuntia ficus-indica, quantity: 7.14 mg/g (equivalent: opuntia ficus-indica, qty 71.4 mg/g); hovenia dulcis, quantity: 7.14 mg/g (equivalent: hovenia dulcis, qty 71.4 mg/g); ascorbic acid, quantity: 3.81 mg/g; caffeine, quantity: 3.81 mg/g - powder, oral - excipient ingredients: maltodextrin; malic acid; citric acid; colloidal anhydrous silica; sucralose; lecithin; flavour - enhance/promote energy levels ; maintain/support energy levels ; decrease/reduce/relieve symptoms of dehydration ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; helps decrease/reduce/relieve symptoms of occasional hangovers ; helps enhance/improve muscle recovery time ; maintain/support mental concentration/focus/clarity ; enhance/improve/promote/increase mental alertness/wakefulness